Article

Tackling heart disease in Kenya

Heart failure is a growing problem in Kenya and other countries in Sub-Saharan Africa. Yet many patients remain undiagnosed due to a lack of healthcare infrastructure and not enough doctors with relevant expertise. Novartis has reached over 95 000 healthcare professionals across the region with an education program designed to strengthen the diagnosis, treatment and management of heart failure. Dr. Juliet Akoth, a doctor at a rural hospital near Nairobi, is one of them.

Published on 12/04/2021

By Andrew Joyce, photos: Getty Images for Novartis

As the primary physician at a rural hospital in Kenya, Dr. Juliet Akoth (left) wears many hats. Despite training as a kidney specialist, Dr. Akoth found that many of her patients at her hospital in Kitui, about four hours from the country’s capital Nairobi, were suffering from cardiovascular issues. She enrolled in Echo for Life, a program sponsored by Novartis in partnership with the University of Nairobi to train healthcare professionals in the diagnosis and treatment of cardiovascular disease.

Dr. Akoth uses a cardiac ultrasound machine. Heart disease causes 25 percent of hospital admissions and 13 percent of deaths in Kenya, according to government data.

Kitui Hospital has reduced waiting times for cardiograms and increased diagnosis of cardiovascular diseases to improve patient care. Here, Dr. Akoth (seated) calls a patient to a consultation room.

Dr. Akoth uses a Butterfly iQ™ ultrasound device, provided by the Echo for Life program, during a visit with a patient in Kitui. The portable devices help to diagnose patients in rural areas, where approximately 70% of Kenyans live and where access to healthcare infrastructure can be difficult.

Dr. Akoth (left) walks with a patient in Kitui.